1. Home
  2. SHC vs GH Comparison

SHC vs GH Comparison

Compare SHC & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$17.37

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$102.76

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
GH
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
14.1B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SHC
GH
Price
$17.37
$102.76
Analyst Decision
Buy
Strong Buy
Analyst Count
6
21
Target Price
$17.80
$96.48
AVG Volume (30 Days)
2.5M
2.0M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$1,150,379,000.00
$902,569,000.00
Revenue This Year
$6.41
$35.00
Revenue Next Year
$5.89
$26.80
P/E Ratio
$88.47
N/A
Revenue Growth
2.67
30.38
52 Week Low
$9.53
$29.91
52 Week High
$17.78
$112.43

Technical Indicators

Market Signals
Indicator
SHC
GH
Relative Strength Index (RSI) 63.37 56.39
Support Level $16.55 $96.28
Resistance Level $17.33 $105.01
Average True Range (ATR) 0.31 4.05
MACD 0.03 -1.12
Stochastic Oscillator 92.92 48.98

Price Performance

Historical Comparison
SHC
GH

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: